Private fee-for-service plans are under scruntiny as perhaps being partly responsible for skyrocketing Medicare expenditures.
WASHINGTON, D.C. - The recent report on the deteriorating financial condition of the Medicare trust funds heightens the sense of urgency in overhauling the nation's high-cost but inefficient healthcare system. The Medicare hospital fund now faces depletion by 2017, two years earlier than the previous projection. The nation's economic decline has reduced tax revenues to support the program, while healthcare spending continues to climb.
Medicare expenditures are expected to increase at a faster pace than either workers' earnings or the overall economy, with outlays rising from 3.2% of gross domestic product (GDP) last year to 11.4% by 2083. These gloomy projections reflect continued growth in the volume and intensity of healthcare services over the next 75 years; an increase in the number of beneficiaries as the baby boomers begin to hit age 65; and the addition of the Part D prescription drug program in 2004.
MA UNDER SCRUTINY
The Medicare actuaries predict a decline in high-cost private-FFS plans (PFFS) over the next few years due to the need to meet provider network requirements. The total MA penetration rate thus no longer is projected to rise to 31% of all Medicare beneficiaries, but to level off at 24% beginning next year.
Further changes in benchmark calculations and payment rates could reduce growth even further. At a briefing on the trustees report at the American Enterprise Institute, HHS Chief Actuary Richard Foster observed that a shift to competitive bidding or alteration in statutory benchmarks would find some MA plans more efficient than FFS. But many plans in rural areas would not be competitive. Former House Ways & Means Committee Chairman Bill Thomas noted that MA plans in all regions may not be cost effective.
"We need to ratchet it down," Thomas said about the MA program, "not kill it off."
Premiums for Employer-based Health Insurance Increased by 7% in 2024, Says KFF Report
Published: October 9th 2024 | Updated: October 9th 2024The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.
Read More
Florida Gets the OK. But Will Drug Importation from Canada Actually Happen?
March 5th 2024Canadian health officials warn that maintaining a drug supply for Canadians is their priority. The staunch opposition of the U.S. pharmaceutical industry may also be an obstacle to imports from north of the border.
Read More
Doug Chaet of Value Evolutions Discusses Value-based Payment Models, Where They Stand and More
September 29th 2022In this episode of Tuning In to the C-Suite, Managing Editor of Managed Healthcare Executive, Peter Wehrwein, speaks with President of Value Evolutions and MHE Editorial Advisory Board Member, Doug Chaet, FACHE, about value-based care's current standing, the status of select payment models like bundled and episodic, and more.
Listen
Parity for Mental Health — Any Progress?
October 12th 2023Laws since 1996 have sought to assure that coverage of behavioral health treatments does not take a back seat to physical medicine. Amid a national crisis in mental illness and addiction, that new world of equality has not arrived. But is it on the way?
Read More